Qualification of NISTmAb charge heterogeneity control assays.

about

The NISTmAb Reference Material 8671 lifecycle management and quality plan.Development of an LC-MS/MS peptide mapping protocol for the NISTmAb.The NISTmAb Reference Material 8671 value assignment, homogeneity, and stability.

P2860

Q50048178-3DD34689-B2FF-44D1-AD9A-E9C401539034 Q50057241-7F4AC8B6-9629-400E-9D5F-6405F5FF3365 Q50146573-AE192642-A698-4D9F-8F20-CDC8760B1498

P2860

Qualification of NISTmAb charge heterogeneity control assays.

Item

http://www.wikidata.org/entity/Q48504883

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Qualification of NISTmAb charge heterogeneity control assays.

@en

Qualification of NISTmAb charge heterogeneity control assays.

@nl

type

Item

label

Qualification of NISTmAb charge heterogeneity control assays.

@en

Qualification of NISTmAb charge heterogeneity control assays.

@nl

prefLabel

Qualification of NISTmAb charge heterogeneity control assays.

@en

Qualification of NISTmAb charge heterogeneity control assays.

@nl

P1476

Qualification of NISTmAb charge heterogeneity control assays.

@en

P2093

John E Schiel

http://www.w3.org/2001/XMLSchema#string

P2860

Worldwide experience with biosimilar development.

Determination of the isoelectric point of proteins by capillary isoelectric focusing.

In-Depth Characterization and Spectral Library Building of Glycopeptides in the Tryptic Digest of a Monoclonal Antibody Using 1D and 2D LC-MS/MS.

Carrier ampholytes for IEF, on their fortieth anniversary (1967-2007), brought to trial in court: the verdict.

Analytical tools for characterizing biopharmaceuticals and the implications for biosimilars.

Characterization of therapeutic antibodies and related products.

Capillary electrophoresis and isoelectric focusing in peptide and protein analysis.

Enhanced Detection of Low-Abundance Host Cell Protein Impurities in High-Purity Monoclonal Antibodies Down to 1 ppm Using Ion Mobility Mass Spectrometry Coupled with Multidimensional Liquid Chromatography.

Cutting-edge capillary electrophoresis characterization of monoclonal antibodies and related products.

A systematic study in CIEF: defining and optimizing experimental parameters critical to method reproducibility and robustness.

P2888

s00216-017-0816-6

P304

2079-2093

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00216-017-0816-6

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

410

http://www.w3.org/2001/XMLSchema#string

P50

Abigail Norris Turner

P577

2018-02-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29423598

http://www.w3.org/2001/XMLSchema#string

P932

5830499

http://www.w3.org/2001/XMLSchema#string

Qualification of NISTmAb charge heterogeneity control assays.

about

P2860

P2860

Qualification of NISTmAb charge heterogeneity control assays.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932